Severe neutropenia probably caused by enzalutamide and abiraterone in a prostate cancer patient.
Article in Journal of Oncology Pharmacy Practice (July 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Article in Journal of Oncology Pharmacy Practice (July 2024)
Article in European Urology Focus (June 2024)
Article in Cancers (May 2024)